A case of klebsiella ornithinolytica bacteremia.
- Author:
Dong Ryoul OH
1
;
Nam Joong KIM
;
Jin Woo SONG
;
Jung Joon CHOI
;
Yong Hak SON
;
Mi Suk LEE
;
Jun Hee WOO
Author Information
1. Division of Infectious Diseases, Asan Medical Center, Ulsan University Hospital, University of Ulsan College of Medicine, Seoul, Korea. njkim@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Klebsiella;
Bacteremia;
Cholangitis
- MeSH:
Aminoglycosides;
Ampicillin;
Anti-Bacterial Agents;
Bacteremia*;
beta-Lactamases;
Bile;
Cefotaxime;
Cephalosporins;
Cholangitis;
Common Bile Duct;
Escherichia coli;
Follow-Up Studies;
Humans;
Klebsiella pneumoniae;
Klebsiella*;
Middle Aged;
Quinolones;
Wounds and Injuries
- From:Korean Journal of Medicine
2003;65(Suppl 3):S890-S893
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Klebsiella ornithinolytica is a very rare Klebsiella species isolated from human. Human strains have been isolated mainly from respiratory secretions, wounds and urine. The clinical features and pathogenic role of human disease with K. ornithinolytica is unknown. We describe a case of K. ornithinolytica bacteremia which developed in a 45-year-old man with acute cholangitis by common bile duct stones. In this case, K. ornithinolytica was sensitive to beta-lactamase inhibitor, all tested cephalosporins, aminoglycosides, quinolones, trimethoprim/sulfameth- oxazole but resistant to ampicillin. After intravenous therapy with cefotaxime, follow up blood culture showed no further growth of K. ornithinolytica. Later, extended-spectrum beta-lactamase (ESBL) producing Klebsiella pneumoniae and Escherichia coli was cultured from bile, so the antibiotics was switched to meropenem. Common bile duct stones was removed by percutaneous transhepatic cholangioscopy (PTCS) and the patient recovered fully without any complication.
